CDC Fyshwick FY2

CDC · Australia

Also recorded as: FY2

Canberra, ACT · facility

Operating / built

Facility type: colocation
Location evidence: Approximate city location
Research status: Source-listed profile · 63% core-field coverage

Core-field coverage counts eight basic fields available in the Atlas. It is not an accuracy score or a measure of technical specification completeness. Individual evidence checks appear below.

Evidence by field

Evidence status applies to the named field and cited sources. “Not found” means those sources do not establish the fact; it does not establish absence.

Certification Source checked: Canberra Data Centres, F2: only the named Certified Strategic facility. This does not certify other buildings or the whole parent campus.Checked 2026-09-22 · Australian Government, Department of Home Affairs ↗
Status Source checked: Operating per the operator's campus page and Infratil's ANZ map.Checked 2026-11-03 · CDC Data Centres ↗ · Infratil Limited ↗
Identity Not found in checked sources: No cited source ties a street number to the FY2 building; see FY1.Checked 2026-11-03 · CDC Data Centres ↗ · CDC Data Centres ↗ · Australian Government Department of Industry, Science and Resources ↗

Capacity & development

Operating / builtNot disclosed

Power basis not established

CDC's Canberra page states the Fyshwick campus is home to FY1 and FY2 with 45 MW operating; Infratil's March 2026 ANZ map lists FY2 among operating data centres. Campus capacity is carried by the CDC Fyshwick Campus record.

CDC Data Centres ↗Infratil Limited ↗

Government certification

Certified Strategic facility

Canberra Data Centres, F2: only the named Certified Strategic facility. This does not certify other buildings or the whole parent campus.

What certification covers →

Scope and context

Added from a public Data Center Map listing. Identity and location remain directory-reported until corroborated against operator or planning evidence.
The directory links this entry to CDC Fyshwick Campus. It shares a grouped site boundary with its reported parent; a hosted provider or child building is not counted as another independent site.

Compute, workloads & commercial commitments

Site-specific workloads, GPU inventory and customer contracts are not established by the cited evidence. Electrical capacity and AI-ready specifications alone do not establish these details.

Related operator-wide evidence

These disclosures describe the operator’s portfolio. They are not assigned to this facility or included in its power totals.

Facility specificationANZAnnouncement

CDC reports a 3.9 GW leasable ANZ pipeline

September 2026 investor update reports 3.9 GW leasable pipeline as at 30 June 2026. Earlier 1.7 GW leasable capacity corresponded to a 2.5 GW built capacity pipeline. The definitions differ and cannot be summed.

Total leasable pipeline: 3,900 MW leasable

Evidence scope: Operator portfolio · CDC
Evidence as-of date: 2026-06-30

How to read this: Includes existing operating and future capacity across Australia and New Zealand. It is not additional pipeline or site-allocated IT capacity and is not additive to facility totals.

Inspect the source

CDC Infratil investor update, 16 September 2026 ↗
CDC / Infratil · checked 2026-09-22 · published 2026-09-16
Slides: CDC Group snapshot; Then and now; Operating capacity has more than doubled; Construction is progressing; footnotes defining pipeline

Link to this evidence ↗

Facility specificationAustraliaOperating deployment

CDC Australian operating ICT capacity: approximately 470 MW

CDC reports operating primary ICT capacity of approximately 120 MW in the ACT, 220 MW in NSW and 130 MW in Victoria at 30 June 2026. The regional figures are rounded to the nearest 10 MW.

Operating primary ICT capacity: ≈ 470 MW IT

Evidence scope: Operator portfolio · CDC
Evidence as-of date: 2026-06-30

How to read this: The portfolio is included once in the operating reconciliation. Brooklyn accounts for the Victorian 130 MW; other named-site allocations remain incomplete. Primary ICT excludes the redundancy and losses in CDC’s earlier built-capacity measure. It is available capacity, not actual consumption.